Additional file 3 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
收藏DataCite Commons2024-02-08 更新2024-08-18 收录
下载链接：
https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Decitabine_in_combination_with_fludarabine_and_cyclophosphamide_as_a_lymphodepletion_regimen_followed_by_CD19_CD22_bispecific_targeted_CAR_T-cell_therapy_significantly_improves_survival_in_relapsed_refractory_B-ALL_pati/22620308
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 3. Clinical Response.
提供机构：
figshare
创建时间：
2023-04-13
